Clinical Trials Browser

Terminated × Recurrence × Trastuzumab × Clear all

NCT00724360 2013-10-07

Trastuzumab for HER2 Positive Relapsed/Refractory B-Acute Lymphoblastic Leukemia (B-ALL)

Phase 2 Terminated

Other hematologic neoplasm

Leukemia, Recurrence

NCT00189579 2007-08-17

Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian Cancer

Phase 2 Terminated

Ovarian Neoplasms, Recurrence